The Stars are Coming Together Again for the Live Broadcast Event "Stand Up to Cancer"

Find Shows Print Friendly Version Convert to PDF     

01 September 2018
rickspicks
Stand Up To Cancer
"Stand Up To Cancer"
Friday, September 7 from 8 to 9 PM ET/PT on ABC
 
          Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation (EIF), announced that the Hollywood community is rallying together yet again to support the sixth biennial televised fundraising special on Friday, Sept. 7 (8:00–9:00 p.m. EDT/PDT and 7:00–8:00 p.m. CDT). Mahershala Ali, Kathy Bates, Katie Couric, Jennifer Garner, Tony Hale, Marg Helgenberger, Ed Helms, Ken Jeong, Marlee Matlin, Matthew McConaughey, Maria Menounos, Jillian Michaels, Trevor Noah, Dak Prescott, Italia Ricci, Rob Riggle, Karla Souza, David Spade, Keith Urban and Reese Witherspoon will participate in this memorable event – marking 10 years since the first telecast and 10 years of SU2C’s lifesaving research achievements.
 
          Bradley Cooper, Academy Award®-nominated actor, will return as co-executive producer along with the renowned live-event producing team Done + Dusted, working again with the Stand Up To Cancer production team, after a successful partnership for the 2016 telecast. 
 

          “As someone whose family has been significantly touched by cancer, I am proud to again have the privilege of co-executive producing this year’s Stand Up To Cancer telecast,” said SU2C co-executive producer Bradley Cooper. “This show reminds everyone that you are never alone … that there is a community of support out there when you need it most. That’s the power of SU2C. Most importantly, the telecast showcases the significant progress being made in the fight against cancer, instilling hope in those facing the disease. This one-hour broadcast unites us all to raise funds for more effective treatments to save lives now.”
 
           The telecast will broadcast live from The Barker Hangar in Santa Monica, California. As in years past, ABC, CBS, FOX and NBC, along with AT&T AUDIENCE Network, Bloomberg TV, Bravo, Discovery Life, E!, EPIX, Escape, ESPNEWS, FM, Freeform, FS2, FXM, FYI, Galavision, HBO, HBO Latino, ION Television, Jewish Life TV, Laff, Logo, MTV2, Nat Geo WILD, PeopleTV, REELZ, SHOWTIME, Smithsonian Channel, STARZ, STARZ ENCORE, STARZ ENCORE ESPAÑOL, TNT, Univision Puerto Rico and WGN America are donating one hour of simultaneous commercial-free prime time for the telecast, with additional networks to be announced. Following the live broadcast, the telecast will be available to stream via ComedyCentral.com and the Comedy Central app, as well as its VOD partners. Aspire TV will air the Stand Up To Cancer telecast on Saturday, Sept. 8 at 8:00–9:00 a.m. EDT/PDT and 10:00 a.m. CDT. The entire telecast will also be available to stream live and on demand on Hulu.
 
          To date, more than $480 million has been pledged in support of SU2C’s innovative cancer research. The organization has brought together more than 1,500 of the best scientists from over 180 leading institutions with an emphasis on collaborative, multidisciplinary teams that deliver new therapies and treatments to cancer patients. Scientists work together on Stand Up To Cancer’s 24 signature “Dream Teams,” among a total of 79 team science grants and awards, whose research is aimed at ending cancer’s reign as a leading cause of death worldwide. SU2C-funded researchers have planned, launched or completed more than 180 clinical trials involving over 12,000 patients.
 
           The results have been exceptional. In just under 10 years, SU2C research has contributed to FDA approval of five new cancer therapies, including treatments for breast, ovarian and pancreatic cancers and difficult-to-treat leukemias. Additional trial results have been submitted or are nearing completion for breast, colon, ovarian and prostate cancers and metastatic melanoma. Stand Up To Cancer has provided substantial funding for the study of immunotherapy in the fight against cancer and has advanced development of technologies using blood tests to identify cancers early, imaging to understand tumor progression and precision medicine via new laboratory tools.
 
             SU2C’s wide-ranging scientific portfolio is overseen by a blue-ribbon scientific advisory committee chaired by Nobel Prize winner Phillip A. Sharp, Ph.D., Institute Professor at the Massachusetts Institute of Technology. Most grants are administered by SU2C’s Scientific Partner, the American Association for Cancer Research (AACR), the world’s first and largest professional organization dedicated to advancing cancer research.
 
< back

You must be logged in to view this item.





This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.